(S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist

Details for Australian Patent Application No. 2004298341 (hide)

Owner UCB Pharma GmbH

Inventors Scheller, Dieter; Hansen, Klaus

Agent Davies Collison Cave

Pub. Number AU-B-2004298341

PCT Pub. Number WO2005/058296

Priority 103 59 528.7 18.12.03 DE

Filing date 13 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 10 March 2011

International Classifications

C07C 211/38 (2006.01) Compounds containing amino groups bound to a carbon skeleton

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058296 Priority application(s): WO2005/058296

16 December 2010 Alteration of Name

  The name of the applicant has been altered to UCB Pharma GmbH

10 March 2011 Application Accepted

  Published as AU-B-2004298341

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298343-COMT inhibitors

2004298336-Purification system